Skip to main content
SpringerLink
Log in

The role of IGF-I and IGFBP-1 status and secondary hyperparathyroidism in relation to osteoporosis in elderly Swedish women

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

IGFBP-1 showed a strong inverse relation to the BMD values. The IGF-I values had a significant positive relation to the BMD values at all sites with the exception of the lumbar spine. The use of loop diuretics was a more important cause of secondary hyperparathyroidism than vitamin D status.

Introduction

Our aim was to investigate among elderly women the relationship to osteoporosis of calcium-regulating hormones and insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-1 (IGFBP-1).

Methods

A population-based cross-sectional study of 350 elderly women (mean age 73 years). Measurements of bone mineral density (BMD) of the left hip, lumbar spine and heel and risk markers for osteoporosis were studied.

Results

The BMD values showed significant inverse relationship with the values of IGFBP-1 at all sites of measurement and significant positive relationship with the values of IGF-I at all sites with the exception of the lumbar spine. There was no significant association between the values of BMD and the values of 25-hydroxy vitamin D (25(OH)D). The use of loop diuretics was strongly and significantly associated with elevated levels of PTH >65 pg/ml (OR 4.4, P < 0.001).

Conclusions

The anabolic growth factor IGF-I and its modulating binding protein IGFBP-1 showed a stronger association with the BMD values than the calcium regulating hormones 25(OH)D and PTH. In this study the use of loop diuretics was a more important cause of secondary hyperparathyroidism than vitamin D status.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Lips P, Duong T, Oleksik A, Black D, Cummings S, Cox D, Nickelsen T (2001) A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 86:1212–1221

    Article  PubMed  CAS  Google Scholar 

  2. Chapuy MC, Schott AM, Garnero P, Hans D, Delmas PD, Meunier PJ (1996) Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. EPIDOS Study Group. J Clin Endocrinol Metab 81:1129–1133

    Article  PubMed  CAS  Google Scholar 

  3. Bischoff-Ferrari HA, Orav EJ, Dawson-Hughes B (2006) Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial. Arch Intern Med 166:424–430

    Article  PubMed  CAS  Google Scholar 

  4. Lips P, Hosking D, Lippuner K, Norquist JM, Wehren L, Maalouf G, Ragi-Eis S, Chandler J (2006) The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med 260:245–254

    Article  PubMed  CAS  Google Scholar 

  5. van der Wielen RP, Lowik MR, van den Berg H, de Groot LC, Haller J, Moreiras O, van Staveren WA (1995) Serum vitamin D concentrations among elderly people in Europe. Lancet 346:207–210

    Article  PubMed  Google Scholar 

  6. Melin AL, Wilske J, Ringertz H, Saaf M (1999) Vitamin D status, parathyroid function and femoral bone density in an elderly Swedish population living at home. Aging (Milano) 11:200–207

    CAS  Google Scholar 

  7. Stein MS, Scherer SC, Walton SL, Gilbert RE, Ebeling PR, Flicker L, Wark JD (1996) Risk factors for secondary hyperparathyroidism in a nursing home population. Clin Endocrinol (Oxf) 44:375–383

    Article  CAS  Google Scholar 

  8. Stein MS, Flicker L, Scherer SC, Paton LM, O’Brien ML, Walton SC, Chick P, Di Carlantonio M, Zajac JD, Wark JD (2001) Relationships with serum parathyroid hormone in old institutionalized subjects. Clin Endocrinol (Oxf) 54:583–592

    Article  CAS  Google Scholar 

  9. Jehle PM, Schulten K, Schulz W, Jehle DR, Stracke S, Manfras B, Boehm BO, Baylink DJ, Mohan S (2003) Serum levels of insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)−1 to −6 and their relationship to bone metabolism in osteoporosis patients. Eur J Intern Med 14:32–38

    Article  PubMed  CAS  Google Scholar 

  10. Boonen S, Lesaffre E, Dequeker J, Aerssens J, Nijs J, Pelemans W, Bouillon R (1996) Relationship between baseline insulin-like growth factor-I (IGF-I) and femoral bone density in women aged over 70 years: potential implications for the prevention of age-related bone loss. J Am Geriatr Soc 44:1301–1306

    PubMed  CAS  Google Scholar 

  11. Campillo B, Paillaud E, Bories PN, Noel M, Porquet D, Le Parco JC (2000) Serum levels of insulin-like growth factor-1 in the three months following surgery for a hip fracture in elderly: relationship with nutritional status and inflammatory reaction. Clin Nutr 19:349–354

    Article  PubMed  CAS  Google Scholar 

  12. Gamero P, Sornay-Rendu E, Delmas PD (2000) Low serum IGF-1 and occurrence of osteoporotic fractures in postmenopausal women. Lancet 355:898–899

    Article  PubMed  CAS  Google Scholar 

  13. Clemmons DR (2004) Role of insulin-like growth factor iin maintaining normal glucose homeostasis. Horm Res 62(Suppl 1):77–82

    Article  PubMed  CAS  Google Scholar 

  14. Thissen JP, Ketelslegers JM, Underwood LE (1994) Nutritional regulation of the insulin-like growth factors. Endocr Rev 15:80–101

    Article  PubMed  CAS  Google Scholar 

  15. Schurch MA, Rizzoli R, Slosman D, Vadas L, Vergnaud P, Bonjour JP (1998) Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 128:801–809

    PubMed  CAS  Google Scholar 

  16. Mohan S, Richman C, Guo R, Amaar Y, Donahue LR, Wergedal J, Baylink DJ (2003) Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms. Endocrinology 144:929–936

    Article  PubMed  CAS  Google Scholar 

  17. Szulc P, Joly-Pharaboz MO, Marchand F, Delmas PD (2004) Insulin-like growth factor I is a determinant of hip bone mineral density in men less than 60 years of age: MINOS study. Calcif Tissue Int 74:322–329

    Article  PubMed  CAS  Google Scholar 

  18. Yamaguchi T, Kanatani M, Yamauchi M, Kaji H, Sugishita T, Baylink DJ, Mohan S, Chihara K, Sugimoto T (2006) Serum levels of insulin-like growth factor (IGF); IGF-binding proteins−3, −4, and −5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women. Calcif Tissue Int 78:18–24

    Article  PubMed  CAS  Google Scholar 

  19. Krassas GE, Papadopoulou P, Koliakos G, Konstantinidis T, Kalothetou K (2003) Growth hormone, insulin growth factor−1, and igf binding protein−3 axis relationship with bone mineral density among healthy men. Arch Androl 49:191–199

    Article  PubMed  CAS  Google Scholar 

  20. Gillberg P, Olofsson H, Mallmin H, Blum WF, Ljunghall S, Nilsson AG (2002) Bone mineral density in femoral neck is positively correlated to circulating insulin-like growth factor (IGF)-I and IGF-binding protein (IGFBP)−3 in Swedish men. Calcif Tissue Int 70:22–29

    Article  PubMed  CAS  Google Scholar 

  21. Langlois JA, Rosen CJ, Visser M, Hannan MT, Harris T, Wilson PW, Kiel DP (1998) Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. J Clin Endocrinol Metab 83:4257–4262

    Article  PubMed  CAS  Google Scholar 

  22. Kim JG, Shin CS, Choi YM, Moon SY, Kim SY, Lee JY (1999) The relationship among circulating insulin-like growth factor components, biochemical markers of bone turnover and bone mineral density in postmenopausal women under the age of 60. Clin Endocrinol (Oxf) 51:301–307

    Article  CAS  Google Scholar 

  23. Jassal SK, von Muhlen D, Barrett-Connor E, Rosen CJ (2005) Serum insulin-like growth factor binding protein−1 levels and bone mineral density in older adults: the Rancho Bernardo Study. Osteoporos Int 16:1948–1954

    Article  PubMed  CAS  Google Scholar 

  24. Hedstrom M (1999) Hip fracture patients, a group of frail elderly people with low bone mineral density, muscle mass and IGF-I levels. Acta Physiol Scand 167:347–350

    Article  PubMed  CAS  Google Scholar 

  25. Salminen H (2005) Osteoporosis in Primary Health Care - some aspects of bone density measurements and nutritional status. In Centre for Family Medicine, Karolinska Institutet. Stockholm, p 52

  26. Salminen H, Saaf M, Ringertz H, Strender LE (2005) Bone mineral density measurement in the calcaneus with DXL: comparison with hip and spine measurements in a cross-sectional study of an elderly female population. Osteoporos Int 16:541–551

    Article  PubMed  CAS  Google Scholar 

  27. Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, Johnston CC, Jr, Lindsay RL (1995) Proximal femur bone mineral levels of US adults. Osteoporos Int 5:389–409

    Article  PubMed  CAS  Google Scholar 

  28. Kullenberg R (2003) Reference database for dual x-ray and laser calscan bone densitometer. J Clin Densitom 6:367–371

    Article  PubMed  Google Scholar 

  29. Povoa G, Roovete A, Hall K (1984) Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinol (Copenh) 107:563–570

    CAS  Google Scholar 

  30. Soderberg S, Ahren B, Eliasson M, Dinesen B, Brismar K, Olsson T (2001) Circulating IGF binding protein−1 is inversely associated with leptin in non-obese men and obese postmenopausal women. Eur J Endocrinol 144:283–290

    Article  PubMed  CAS  Google Scholar 

  31. Hilding A, Hall K, Wivall-Helleryd IL, Saaf M, Melin AL, Thoren M (1999) Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19–82 years, in relation to those in healthy subjects. J Clin Endocrinol Metab 84:2013–2019

    Article  PubMed  CAS  Google Scholar 

  32. Unden AL, Elofsson S, Knox S, Lewitt MS, Brismar K (2002) IGF-I in a normal population: relation to psychosocial factors. Clin Endocrinol (Oxf) 57:793–803

    Article  CAS  Google Scholar 

  33. Thorslund S, Toss G, Nilsson I, von Schenck H, Symreng T, Zetterqvist H (1990) Prevalence of protein-energy malnutrition in a large population of elderly people at home. Scand J Prim Health Care 8:243–248

    Article  PubMed  CAS  Google Scholar 

  34. Lindgren BF, Friis K, Ericsson F (2000) Insulin-like growth factor I correlates with protein intake estimated from the normalized protein catabolic rate in hemodialysis patients. Am J Nephrol 20:255–262

    Article  PubMed  CAS  Google Scholar 

  35. Ponzer S, Tidermark J, Brismar K, Soderqvist A, Cederholm T (1999) Nutritional status, insulin-like growth factor−1 and quality of life in elderly women with hip fractures. Clin Nutr 18:241–246

    Article  PubMed  CAS  Google Scholar 

  36. Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:477–501

    Article  PubMed  CAS  Google Scholar 

  37. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, Meunier PJ (1997) Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7:439–443

    Article  PubMed  CAS  Google Scholar 

  38. Arunabh S, Pollack S, Yeh J, Aloia JF (2003) Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab 88:157–161

    Article  PubMed  CAS  Google Scholar 

  39. Kado DM, Browner WS, Blackwell T, Gore R, Cummings SR (2000) Rate of bone loss is associated with mortality in older women: a prospective study. J Bone Miner Res 15:1974–1980

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported financially by grants from the Stockholm County Council and Karolinska Institutet.

Author information

Authors and Affiliations

  1. Centre for Family and Community Medicine, Karolinska Institutet, Stockholm, Sweden

    H. Salminen & L. E. Strender

  2. Department of Endocrinology, Metabolism and Diabetes, Karolinska University Hospital, and Karolinska Institutet, Stockholm, Sweden

    M. Sääf

  3. Department of Surgical Sciences, Section for Diagnostic Radiology, Karolinska Institutet, Stockholm, Sweden

    H. Ringertz

  4. Centre for Family and Community Medicine, Alfred Nobels allé 12, S-14183, Huddinge, Sweden

    H. Salminen

Authors
  1. H. Salminen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Sääf
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Ringertz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. E. Strender
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Salminen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Salminen, H., Sääf, M., Ringertz, H. et al. The role of IGF-I and IGFBP-1 status and secondary hyperparathyroidism in relation to osteoporosis in elderly Swedish women. Osteoporos Int 19, 201–209 (2008). https://doi.org/10.1007/s00198-007-0463-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-007-0463-4

Keywords

Search

Navigation